These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26270258)

  • 1. Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance.
    Zhao Y; Chen F; Pan Y; Li Z; Xue X; Okeke CI; Wang Y; Li C; Peng L; Wang PC; Ma X; Liang XJ
    ACS Appl Mater Interfaces; 2015 Sep; 7(34):19295-305. PubMed ID: 26270258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistically Enhanced Therapeutic Effect of a Carrier-Free HCPT/DOX Nanodrug on Breast Cancer Cells through Improved Cellular Drug Accumulation.
    Chen F; Zhao Y; Pan Y; Xue X; Zhang X; Kumar A; Liang XJ
    Mol Pharm; 2015 Jul; 12(7):2237-44. PubMed ID: 25996761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein/DOX nanodispersions.
    Wang R; Yang Y; Yang M; Yuan D; Huang J; Chen R; Wang H; Hu L; Di L; Li J
    J Nanobiotechnology; 2020 Aug; 18(1):116. PubMed ID: 32847586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy.
    Zhang Y; Xiao C; Li M; Chen J; Ding J; He C; Zhuang X; Chen X
    Macromol Biosci; 2013 May; 13(5):584-94. PubMed ID: 23420692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Targeted, Shape-Assisted, and Controlled-Release Self-Delivery Nanodrug for Synergistic Targeting/Anticancer Effect of Cytoplasm and Nucleus of Cancer Cells.
    Li Y; Lin J; Huang Y; Li Y; Yang X; Wu H; Wu S; Xie L; Dai L; Hou Z
    ACS Appl Mater Interfaces; 2015 Nov; 7(46):25553-9. PubMed ID: 26529185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier-free, self-assembled pure drug nanorods composed of 10-hydroxycamptothecin and chlorin e6 for combinatorial chemo-photodynamic antitumor therapy in vivo.
    Wen Y; Zhang W; Gong N; Wang YF; Guo HB; Guo W; Wang PC; Liang XJ
    Nanoscale; 2017 Oct; 9(38):14347-14356. PubMed ID: 28731112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
    Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z
    Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
    Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
    Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells.
    Misra R; Sahoo SK
    Mol Pharm; 2011 Jun; 8(3):852-66. PubMed ID: 21480667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells.
    Miao J; Du YZ; Yuan H; Zhang XG; Hu FQ
    Colloids Surf B Biointerfaces; 2013 Oct; 110():74-80. PubMed ID: 23711779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.
    Rui M; Qu Y; Gao T; Ge Y; Feng C; Xu X
    Int J Nanomedicine; 2017; 12():217-237. PubMed ID: 28115844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
    J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs.
    Li WM; Su CW; Chen YW; Chen SY
    Acta Biomater; 2015 Mar; 15():191-9. PubMed ID: 25542535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
    Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
    Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.